< Back to Article

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

Table 2

Participant minimisation factors.

doi: https://doi.org/10.1371/journal.pmed.1004120.t002